z-logo
open-access-imgOpen Access
[Reply to Letter to the Editor in reference to " Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”]
Author(s) -
Lorenzo Pradelli,
Paolo A. Ascierto
Publication year - 2017
Publication title -
farmeconomia health economics and therapeutic pathways
Language(s) - English
Resource type - Journals
eISSN - 1721-6923
pISSN - 1721-6915
DOI - 10.7175/fe.v18i1.1329
Subject(s) - dabrafenib , trametinib , melanoma , medicine , cancer research , metastatic melanoma , biology , vemurafenib , mapk/erk pathway , kinase , microbiology and biotechnology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom